American Society of Hematology

Subscribe to RSS

You must select a month AND year to filter.

• This Week in Blood: May 9, 2013
• May 9, 2013
• Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, and Deputy Editor Nancy Berliner, MD. If you would like a PDF copy of any of the manuscripts highlighted below or would like to request an interview with the author, please email aszabo@hematology.org.

• May 2013 Practice Update (part one)
• May 9, 2013
• May 2013 Practice Update (part one)

• Statement from ASH President Janis L. Abkowitz, MD, on the Introduction of the Cancer Drug Coverage Parity Act in the U.S. House of Representatives
• May 2, 2013
• The American Society of Hematology applauds the introduction of the Cancer Drug Coverage Parity Act in the U.S. House of Representatives by Representatives Brian Higgins (D-NY) and Peter King (R-NY). This important legislation would require private health plans offering intravenous chemotherapy benefits to plan subscribers to provide parity for orally administered and self-injectable anticancer chemotherapy medications, greatly reducing the financial burden that patients with blood and other cancers currently face in order to take these life-saving therapies.

• This Week in Blood: May 2, 2013
• May 2, 2013

• Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of ASH, hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, and Deputy Editor Nancy Berliner, MD. 

   

• Applications Now Being Accepted for NIH Translational Health Disparities Course - Due May 15, 2013
• May 1, 2013

• The National Institute on Minority Health and Health Disparities (NIMHD) is now accepting applications for its 2013 Translational Health Disparities Course scheduled for August 5-16 on the NIH campus in Bethesda.

• This Week in Blood: April 26, 2013
• April 26, 2013

• Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, and Deputy Editor Nancy Berliner, MD. If you would like a PDF copy of any of the manuscripts highlighted below or would like to request an interview with the author, please email aszabo@hematology.org. 

   

• Leading Leukemia Experts: High Leukemia Treatment Costs May Be Harming Patients
• April 25, 2013
• The increasing cost of treatments for chronic myeloid leukemia in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than 15 countries on five continents and published online today.

• April 2013 Practice Update (part two)
• April 25, 2013
• April 2013 Practice Update (part two)

• Representatives Higgins & King To Introduce Cancer Oral Drug Parity Legislation; ASH Advocates for Patients to Have Equal Access to Treatment
• April 25, 2013
• On Friday, April 26, Representative Brian Higgins (D-NY) and Peter King (R-NY) will introduce the bi-partisan Cancer Drug Coverage Parity Act in the U.S. House of Representatives.

• This Week in Blood: April 18, 2013
• April 18, 2013
• Welcome to “This Week in Blood ,” a weekly snapshot of the hottest studies from each week’s issue of Blood , the official journal of the American Society of Hematology, hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, and Deputy Editor Nancy Berliner, MD.

• April 2013 Advocacy Update
• April 18, 2013
• April 2013 Advocacy Update

• Key Bone Marrow Protein Identified as Potential New Leukemia Treatment Target
• April 15, 2013
• A new study on how the progression of acute lymphocytic leukemia is influenced by the bone marrow environment has demonstrated for the first time that targeting a specialized protein known as osteopontin may be an effective strategy to increase the efficacy of chemotherapy in patients with this type of blood cancer.

• NHLBI Seeks Proposals for The National Myelodysplastic Syndromes (MDS) Natural History Study
• April 15, 2013
• The National Heart, Lung, and Blood Institute (NHLBI) released two requests for proposals for the National Myelodysplastic Syndromes (MDS) Natural History Study under the following solicitations posted on FedBizOpps.

• This Week in Blood: April 11, 2013
• April 11, 2013

• Welcome to “This Week in Blood ,” a weekly snapshot of the hottest studies from each week’s issue of Blood , the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, and Deputy Editor Nancy Berliner, MD. If you wou

• April 2013 Practice Update (part one)
• April 11, 2013
• April 2013 Practice Update (part one)

< Prev Next > Page 1 of 163